Recombinant expression of cec-b peptide in escherichia coli with a sig-nificant anticancer effect on hepatocellular carcinoma

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Okasha H.; Nasr S.M.; Samir S.

Journal: Current Pharmaceutical Biotechnology

Publisher: Bentham Science Publishers

Publication Date: July 2021

Volume / Issue: Volume 22 / Issue 9

Pages: 1235–1245

ISSN: 13892010

DOI: 10.2174/1389201022666210104121709

Scopus: View on Scopus

PubMed: 33397234

Document Type: Article


Authors and Affiliations

Okasha H., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Nasr S.M., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Samir S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Background: Cecropin-B (Cec-B) is an Antimicrobial Peptide (AMP) found in insects. Objectives: Recombinant production of Cec-B peptide in Escherichia coli (Rosetta™ DE3), and studying its anticancer effect on Hepatocellular Carcinoma Cell line (HCC). Methods: The Cec-B gene of Drosophila melanogaster was synthesized by PCR assembly using the Simplified Gene Synthesis (SGS) method. To express the recombinant peptide in E. coli (Rosetta™ DE3); the synthesized gene was cloned into pET-15b expression vector. The recombinant peptide was expressed as insoluble aggregates called Inclusion Bodies (IBs) using 2mM lactose inducer. IBs were solubilized in a denatured form using 8 M urea followed by in-vitro protein refolding using rapid dilution method. The refolded Cec-B was purified using cation-exchange SP-FF column. Cy-totoxicity of recombinant Cec-B (rCec-B) was reported on normal human lung cell line (WI-38), and Hepatocellular carcinoma cell line (HepG2). Results: The Cec-B gene was expressed and purified at concentration 1.212±0.1 mg/ml which rep-resents 48.49±4% of the total proteins injected to the column (2.5±0.2 mg/ml). The safe dose of purified rCec-B on normal WI-38 cells was calculated to be 1.57 mg/ml. The half-maximal Inhibitory Concentration (IC50) of rCec-B on HepG2 cell line was calculated to be 25 µg/ml. Scanning Electron Microscope (SEM) showed that untreated and treated HepG2 cells had cell diameters from 11-12.92 μm and 14.18-21.58 μm, respectively. Conclusion: The results of this study revealed a successful expression of the rCec-B peptide using a pET-based expression system with a simple purification step. The purified peptide could be consid-ered as a hopeful anticancer drug against HCC. © 2021 Bentham Science Publishers.


Keywords

Anticancer peptide; Cecropin-B; Escherichia coli; Hepatocellular carcinoma; Peptide; Recombinant expression; Antimicrobial Cationic Peptides; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cloning, Molecular; Humans; Inclusion Bodies; Insect Proteins; Liver Neoplasms; Recombinant Proteins; 4 (2 hydroxyethyl) 1 piperazineethanesulfonic acid; agarose; alcohol; amphotericin B deoxycholate; ampicillin; antineoplastic agent; arginine; buffer; carbon dioxide; cecropin B; chloramphenicol; dithiothreitol; DNA ligase; doxorubicin; edetic acid; formazan; glutaraldehyde; gold; lactose; oligonucleotide; osmium tetraoxide; palladium; phosphate buffered saline; restriction endonuclease; sodium chloride; trometamol; type II site specific deoxyribonuclease; urea; antimicrobial cationic peptide; cecropin B protein, Insecta; insect protein; recombinant protein; agar gel electrophoresis; antineoplastic activity; Article; bacterial cell; cell inclusion; cell viability; centrifugation; cytotoxicity; DNA extraction; Drosophila melanogaster; expression vector; fast protein liquid chromatography; fetal bovine serum; gene expression; gene synthesis; Hep-G2 cell line; hepatocellular carcinoma cell line; IC50; incubation time; ionic strength; liver cell carcinoma; microtiter plate assay; molecular weight; MTT assay; nonhuman; polyacrylamide gel electrophoresis; polymerase chain reaction; protein refolding; purification; scanning electron microscopy; spectrophotometry; WI-38 cell line; biosynthesis; chemistry; drug effect; genetics; human; isolation and purification; liver tumor; metabolism; molecular cloning; pathology; tumor cell line


Citation Information

Scopus Citations: 14


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer